CC
SGHT icon

Centiva Capital’s Sight Sciences SGHT Stock Holding History

Centiva Capital’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,598
Closed -$89K – 2173
2026
Q1 		$89K Sell
23,598
-13,882
-37% -$74.9K ﹤0.01% 1404
2025
Q4 		$297K Buy
+37,480
New +$239K ﹤0.01% 851

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Centiva Capital's SGHT Position: Q2 2026 in Review

Centiva Capital sold out of Sight Sciences (SGHT) in Q2 2026, closing a stake of 23,598 shares — an estimated $89K sold.

Centiva Capital first reported a position in SGHT in Q4 2025 and held it in 2 quarters. The position peaked at $297K in Q4 2025. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Centiva Capital reported no remaining Sight Sciences position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 23,598 Sight Sciences shares in Q2 2026, an estimated $89K.
  • Centiva Capital first reported a position in Sight Sciences in Q4 2025 and held it in 2 quarters.
  • Centiva Capital's Sight Sciences position peaked at $297K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.